Crinetics Pharmaceuticals Research and Development Expenses 2017-2024 | CRNX

Crinetics Pharmaceuticals research and development expenses for the twelve months ending September 30, 2024 were $0.219B, a 37.03% increase year-over-year.

  • Crinetics Pharmaceuticals annual research and development expenses for 2023 were $0.169B, a 29.41% increase from 2022.
  • Crinetics Pharmaceuticals annual research and development expenses for 2022 were $0.13B, a 54.56% increase from 2021.
  • Crinetics Pharmaceuticals annual research and development expenses for 2021 were $0.084B, a 47.82% increase from 2020.

Crinetics Pharmaceuticals Research and Development Expenses 2017-2024 | CRNX

  • Crinetics Pharmaceuticals annual research and development expenses for 2023 were $0.169B, a 29.41% increase from 2022.
  • Crinetics Pharmaceuticals annual research and development expenses for 2022 were $0.13B, a 54.56% increase from 2021.
  • Crinetics Pharmaceuticals annual research and development expenses for 2021 were $0.084B, a 47.82% increase from 2020.